secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKWELL MEDICAL, INC. (RMTI)
CIK:        0001041024
Form:       8-K
Filed at:   2025-03-20T23:59:59+00:00
Accession:  0001104659-25-025782
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Rockwell Medical Reports Record Net Sales and First Full-Year Adjusted EBITDA Profitability in 2024
--------------------------------------------------------------------------------

- Record net sales of $101.5M in 2024, a 21% increase over 2023.
- Record gross profit of $17.5M in 2024, a 101% increase over 2023.
- Full-year adjusted EBITDA reached $5.2M, first time profitable on that basis.
- Net loss improved 94% to $0.5M in 2024 from $8.4M in 2023.
- Largest customer transitioning away; expects ~$34M revenue loss in 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1041024/000110465925025782/0001104659-25-025782-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1041024/000110465925025782/tm259810d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-025782

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer